UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Management of recurrent nasopharyngeal carcinoma: current perspectives

OncoTargets and therapy, 2019-01, Vol.12, p.1583-1591

2019

Volltextzugriff (PDF)

A randomized, phase 2 study of cetuximab plus cisplatin with or without paclitaxel for the first-line treatment of patients with recurrent and/or metastatic squamous cell carcinoma of the head and neck

Annals of oncology, 2017-11, Vol.28 (11), p.2820-2826

2017

Volltextzugriff (PDF)

Translational Research: A Future Strategy for Managing Squamous Cell Carcinoma of the Head and Neck?

Anti-cancer agents in medicinal chemistry, 2018-01, Vol.18 (9), p.1220-1227

2018

Volltextzugriff (PDF)

The ErbB receptors and their ligands in cancer: an overview

Current drug targets, 2005-05, Vol.6 (3), p.243-257

2005

Volltextzugriff (PDF)

Afatinib versus methotrexate in older patients with second-line recurrent and/or metastatic head and neck squamous cell carcinoma: subgroup analysis of the LUX-Head & Neck 1 trial

Annals of oncology, 2016-08, Vol.27 (8), p.1585-1593

2016

Volltextzugriff (PDF)

Patient preference and pharmacokinetics of oral modulated UFT versus intravenous fluorouracil and leucovorin: a randomised crossover trial in advanced colorectal cancer

European journal of cancer (1990), 2002-02, Vol.38 (3), p.349-358

2002

Volltextzugriff (PDF)

Phase I and Pharmacokinetic Study of PKC412, an Inhibitor of Protein Kinase C

Journal of clinical oncology, 2001-03, Vol.19 (5), p.1485-1492

2001

Volltextzugriff (PDF)

The ubiquitin-proteasome system as a molecular target in solid tumors: an update on bortezomib

OncoTargets and therapy, 2009-02, Vol.2, p.171-178

2009

Volltextzugriff (PDF)

Isoprenylation of intracellular proteins as a new target for the therapy of human neoplasms: preclinical and clinical implications

Current drug targets, 2005-05, Vol.6 (3), p.301-323

2005

Volltextzugriff (PDF)

583 Induction Chemotherapy with Docetaxel, Cisplatin and Capecitabine, Followed by Combined Cetuximab and Radiotherapy in Patients with Locally Advanced Inoperable Head and Neck Cancer. Preliminary Results of a Phase I/II Study

European journal of cancer (1990), 2012-11, Vol.48, p.178-179

2012

Volltextzugriff (PDF)

Electrochemotherapy, a novel integrated approach to the locoregional treatment of head and neck cancer

European journal of surgical oncology, 2012-10, Vol.38 (10), p.1007-1007

2012

Volltextzugriff (PDF)

An EORTC phase I study of Bortezomib in combination with oxaliplatin, leucovorin and 5-fluorouracil in patients with advanced colorectal cancer

European journal of cancer (1990), 2009-01, Vol.45 (1), p.48-55

2009

Volltextzugriff (PDF)

OC-005: Afatinib versus methotrexate in recurrent/metastatic HNSCC after platinum therapy: LUX-head and neck

Radiotherapy and oncology, 2015-02, Vol.114, p.7-8

2015

Volltextzugriff (PDF)

Epidermal growth factor receptor (EGFR) signaling in cancer

Gene, 2006-01, Vol.366 (1), p.2-16

2006

Volltextzugriff (PDF)

Therapy of metastatic bladder carcinoma

Annals of oncology, 2007-06, Vol.18 (suppl-6), p.vi153-vi156

2007

Volltextzugriff (PDF)

Multicentre EORTC study 16997: Feasibility and phase II trial of farnesyl transferase inhibitor & gemcitabine combination in salvage treatment of advanced urothelial tract cancers

European journal of cancer (1990), 2005-05, Vol.41 (8), p.1150-1157

2005

Volltextzugriff (PDF)

Treatment approaches to nasopharyngeal carcinoma: a review

Anti-cancer drugs, 2010-06, Vol.21 (5), p.471-477

2010

Volltextzugriff (PDF)

Phase II study of E7070 in patients with metastatic melanoma

Annals of oncology, 2005-01, Vol.16 (1), p.158-161

2005

Volltextzugriff (PDF)

Phase I dose-escalation study of brostallicin, a minor groove binder, in combination with cisplatin in patients with advanced solid tumors

Cancer chemotherapy and pharmacology, 2010-07, Vol.66 (2), p.389-394

2010

Volltextzugriff (PDF)

Immunotherapy may protect cancer patients from SARS-CoV-2 infection: a single-center retrospective analysis

Journal of translational medicine, 2021-03, Vol.19 (1), p.132-132, Article 132

2021

Volltextzugriff (PDF)

Phase I study of Caelyx (doxorubicin HCL, pegylated liposomal) in recurrent or metastatic head and neck cancer

Annals of oncology, 2000-03, Vol.11 (3), p.339-342

2000

Volltextzugriff (PDF)

862MO Gene expression profile differentiates short-term and long-term survivors with immunotherapy in patients with recurrent/metastatic head and neck cancer

Annals of oncology, 2021-09, Vol.32, p.S788-S788

2021

Volltextzugriff (PDF)

Docetaxel induces p53-dependent apoptosis and synergizes with farnesyl transferase inhibitor r115777 in human epithelial cancer cells

Frontiers in bioscience, 2005-09, Vol.10 (1-3), p.2566

2005

Volltextzugriff (PDF)

Docetaxel and cisplatin in locally advanced or metastatic squamous-cell carcinoma of the head and neck: A phase II study of the Southern Italy Cooperative Oncology Group (SICOG)

Annals of oncology, 2001-02, Vol.12 (2), p.199-202

2001

Volltextzugriff (PDF)

A single-arm, open-label, multicenter, phase IIIb clinical trial with nivolumab in subjects with recurrent or metastatic platinum-refractory squamous cell carcinoma of the head and neck

Annals of oncology, 2019-10, Vol.30, p.v463

2019

Volltextzugriff (PDF)

1 – 25 von 115

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(105)
Mit Volltextzugriff
(87)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

Science & Technology
(73)
Life Sciences & Biomedicine
(72)
Humans
(64)
Oncology
(56)
Female
(39)
Middle Aged
(38)
Aged
(36)
Male
(35)
Adult
(33)
Chemotherapy
(33)
Biological And Medical Sciences
(31)
Medical Sciences
(30)
Pharmacology. Drug Treatments
(29)
Antineoplastic Agents
(28)
Antineoplastic Combined Chemotherapy Protocols - Therapeutic Use
(23)
Pharmacology & Pharmacy
(19)
Antineoplastic Agents - Therapeutic Use
(16)
Head And Neck Neoplasms - Drug Therapy
(16)
Antineoplastic Combined Chemotherapy Protocols - Adverse Effects
(13)
Treatment Outcome
(12)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Management of recurrent nasopharyngeal carcinoma: current perspectives

A randomized, phase 2 study of cetuximab plus cisplatin with or without paclitaxel for the first-line treatment of patients with recurrent and/or metastatic squamous cell carcinoma of the head and neck

Translational Research: A Future Strategy for Managing Squamous Cell Carcinoma of the Head and Neck?

The ErbB receptors and their ligands in cancer: an overview

Afatinib versus methotrexate in older patients with second-line recurrent and/or metastatic head and neck squamous cell carcinoma: subgroup analysis of the LUX-Head & Neck 1 trial

Patient preference and pharmacokinetics of oral modulated UFT versus intravenous fluorouracil and leucovorin: a randomised crossover trial in advanced colorectal cancer

Phase I and Pharmacokinetic Study of PKC412, an Inhibitor of Protein Kinase C

The ubiquitin-proteasome system as a molecular target in solid tumors: an update on bortezomib

Isoprenylation of intracellular proteins as a new target for the therapy of human neoplasms: preclinical and clinical implications

583 Induction Chemotherapy with Docetaxel, Cisplatin and Capecitabine, Followed by Combined Cetuximab and Radiotherapy in Patients with Locally Advanced Inoperable Head and Neck Cancer. Preliminary Results of a Phase I/II Study

Electrochemotherapy, a novel integrated approach to the locoregional treatment of head and neck cancer

An EORTC phase I study of Bortezomib in combination with oxaliplatin, leucovorin and 5-fluorouracil in patients with advanced colorectal cancer

OC-005: Afatinib versus methotrexate in recurrent/metastatic HNSCC after platinum therapy: LUX-head and neck

Epidermal growth factor receptor (EGFR) signaling in cancer

Therapy of metastatic bladder carcinoma

Multicentre EORTC study 16997: Feasibility and phase II trial of farnesyl transferase inhibitor & gemcitabine combination in salvage treatment of advanced urothelial tract cancers

Treatment approaches to nasopharyngeal carcinoma: a review

Phase II study of E7070 in patients with metastatic melanoma

Phase I dose-escalation study of brostallicin, a minor groove binder, in combination with cisplatin in patients with advanced solid tumors

Immunotherapy may protect cancer patients from SARS-CoV-2 infection: a single-center retrospective analysis

Phase I study of Caelyx (doxorubicin HCL, pegylated liposomal) in recurrent or metastatic head and neck cancer

862MO Gene expression profile differentiates short-term and long-term survivors with immunotherapy in patients with recurrent/metastatic head and neck cancer

Docetaxel induces p53-dependent apoptosis and synergizes with farnesyl transferase inhibitor r115777 in human epithelial cancer cells

Docetaxel and cisplatin in locally advanced or metastatic squamous-cell carcinoma of the head and neck: A phase II study of the Southern Italy Cooperative Oncology Group (SICOG)

A single-arm, open-label, multicenter, phase IIIb clinical trial with nivolumab in subjects with recurrent or metastatic platinum-refractory squamous cell carcinoma of the head and neck

Suchergebnisse filtern